EUVIMEDEUVIMED entdecken
Crossref

Bevacizumab in Combination with Interferon Alpha in Metastatic Renal Cell Carcinoma: The Emerging Evidence of Its Therapeutic Value

Clinical Medicine Reviews in Oncology · 2011

DOI: 10.4137/cmro.s3401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2011. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2011). Bevacizumab in Combination with Interferon Alpha in Metastatic Renal Cell Carcinoma: The Emerging Evidence of Its Therapeutic Value. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3401

Vancouver

Bevacizumab in Combination with Interferon Alpha in Metastatic Renal Cell Carcinoma: The Emerging Evidence of Its Therapeutic Value. Clinical Medicine Reviews in Oncology. 2011. doi:10.4137/cmro.s3401

BibTeX
@article{euvimed2011,
  title = {Bevacizumab in Combination with Interferon Alpha in Metastatic Renal Cell Carcinoma: The Emerging Evidence of Its Therapeutic Value},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2011},
  doi = {10.4137/cmro.s3401}
}
Kostenlos starten →